Organicell Regenerative Medicine (BPSR) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free BPSR Stock Alerts $1.30 +0.05 (+4.00%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesInsider TradesSEC FilingsStock AnalysisChartFinancialsHeadlinesInsider TradesSEC Filings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineZEO ScientifiX, Inc.: Organicell Regenerative Medicine Rebranding to ZEO ScientifiXfinanznachrichten.de - March 4 at 8:04 PMOrganicell Regenerative Medicine Inc (OCELD)uk.investing.com - December 17 at 8:16 PMOCELD Organicell Regenerative Medicine, Inc.seekingalpha.com - December 2 at 12:33 AMOrganicell Regenerative Stock (OTC:OCEL) Dividends: History, Yield and Datesbenzinga.com - November 30 at 12:57 AMOrganicell Announces 1-for-200 Reverse Stock Splitfinance.yahoo.com - November 27 at 8:15 PMOrganicell Regenerative Medicine, Inc.: Organicell Reports Interim Results of Phase 1/2A Research Programfinanznachrichten.de - July 28 at 9:33 AMOrganicell Reports Interim Results of Phase 1/2A Research Programfinance.yahoo.com - July 26 at 4:31 PMOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOfinanznachrichten.de - June 29 at 12:10 PMOrganicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSOfinance.yahoo.com - June 29 at 12:10 PMOrganicell Regenerative Medicine, Inc.: Organicell Welcomes Harry Leider, MD, MBA as its New CEOfinanznachrichten.de - June 23 at 8:34 AM8-K: Organicell Regenerative Medicine, Inc.marketwatch.com - June 22 at 7:32 PMOrganicell Welcomes Harry Leider, MD, MBA as its New CEOfinance.yahoo.com - June 21 at 1:24 PMGlobal Regenerative Medicine Market [2023-2030] | Latest Trends and Insights | Market to Reach Worth USD 116410 Millionmarketwatch.com - May 5 at 5:54 PMCan regenerative wool make fashion more sustainable?bbc.com - May 4 at 8:52 AMOrganicell Regenerative Medicine Inc (OCEL)investing.com - April 6 at 10:50 PMOCEL Organicell Regenerative Medicine, Inc.seekingalpha.com - April 5 at 4:23 PMRegenerative Medicine Market Trends for Future Success 2023-2028marketwatch.com - March 29 at 3:06 PMRegenerative Medicine Market 2023: Growing Opportunities by 2028marketwatch.com - March 29 at 3:06 PMRegenerative Medicine Market Report 2023-2033finance.yahoo.com - March 18 at 9:34 AMMount Vernon, IN Regenerative Medicine Procedures Launched By NuYou Therapiesfinance.yahoo.com - February 22 at 4:12 PMRegenerative Medicine Market Regional Outlook & Size Projections with SWOT Analysis to Witness Rapid Growth 2026marketwatch.com - January 17 at 5:45 PMRegenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical Ailmentsfinance.yahoo.com - January 14 at 10:43 PMRegenerative Medicine for Cartilage Market Industry Expansion Strategies till 2028 with SWOT & RISK Analysismarketwatch.com - January 14 at 10:43 PMOrganicell Regenerative Medicine Inc.wsj.com - January 14 at 12:41 PMThe Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic Conditionsfinance.yahoo.com - January 11 at 10:33 AMRegenerative Medicine Market worth $40.6 billion by 2027 - Exclusive Report by MarketsandMarkets™finance.yahoo.com - January 7 at 2:27 PMOTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷finance.yahoo.com - November 22 at 3:57 PMOrganicell Starts Enrolling Long COVID Trialca.finance.yahoo.com - November 17 at 1:20 PMCan This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?yahoo.com - November 17 at 12:30 AMEQS-News: Can This Companys Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?markets.businessinsider.com - November 14 at 12:20 PMCan This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?benzinga.com - November 14 at 9:36 AMIs It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?benzinga.com - November 10 at 6:57 PMOrganicell Regenerative Medicine, Inc. (OCEL)sg.finance.yahoo.com - October 19 at 7:34 AMOrganicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of Directorsbenzinga.com - October 13 at 4:26 PMOrganicell Regenerative Medicine secures additional $11M financing for clinical trial enrollmentseekingalpha.com - September 9 at 10:37 AMOrganicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial Enrollmentapnews.com - September 9 at 10:37 AMOrganicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & Emeryfinance.yahoo.com - August 30 at 2:56 PMOrganicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activitiesfinance.yahoo.com - December 29 at 8:28 AMOrganicell Regenerative Medicine, Inc. Uplist Of Common Stock To OTCQB Approvedfinance.yahoo.com - November 9 at 1:30 PMFINRA Approves Marketplace Name Change to Organicell Regenerative Medicine, Inc. and Trading Symbol Change To "OCEL"finance.yahoo.com - November 5 at 1:38 PMOrganicell Regenerative Medicine, Inc. (BPSR)finance.yahoo.com - August 13 at 12:50 AM Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. BPSR Media Mentions By Week BPSR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPSR News Sentiment▼0.000.32▲Average Medical News Sentiment BPSR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPSR Articles This Week▼00▲BPSR Articles Average Week Get Organicell Regenerative Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for BPSR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BPSR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organicell Regenerative Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
